Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
03/2012
03/29/2012WO2012037616A1 Interferon-nu
03/29/2012WO2012017434A3 Guanine nucleotide derivatives for treating bacterial infections
03/29/2012WO2011150181A3 Compositions and methods for treating or inhibiting infection by francisella tularensis
03/29/2012WO2011142573A3 Vaccine composition containing a wta as an active ingredient
03/29/2012WO2011140519A3 In vivo gelling pharmaceutical pre-formulation
03/29/2012WO2011139791A3 Bisphosphonamidate prodrugs and uses thereof
03/29/2012WO2011137376A9 Compounds for anti-fungal treatment
03/29/2012WO2011119517A3 Antimicrobial compositions
03/29/2012US20120078165 Element for implantation with medical device
03/29/2012US20120077876 Method For Improved Bioactivation Of Pharmaceuticals
03/29/2012US20120077875 Composition including at least one trans-cinnamaldehyde and the use thereof in the treatment of bacterial infections, specifically in the treatment of nosocomial infections
03/29/2012US20120077866 Antisense modulation of c-reactive protein expression
03/29/2012US20120077856 Pharmaceutical product
03/29/2012US20120077855 Crystalline tripeptide epoxy ketone protease inhibitors
03/29/2012US20120077835 Formulations of rifaximin and uses thereof
03/29/2012US20120077830 Caspase inhibitors and uses thereof
03/29/2012US20120077826 [6,5] - bicyclic gpr119 g protein-coupled receptor agonists
03/29/2012US20120077824 Itraconazole formulations
03/29/2012US20120077823 Controlled release systems of pluribioactive antifungal drugs and applications thereof
03/29/2012US20120077822 In situ-formed bioactive tissue adherent films of absorbable crystallizable polymers
03/29/2012US20120077813 Imidazole Substituted Pyrimidines Useful in the Treatment of Glycogen Synthase Kinase-3 Related Disorders such as Alzheimer's Disease
03/29/2012US20120077806 Deubiquitinase Inhibitors and Methods for Use of the Same
03/29/2012US20120077787 Organic compounds
03/29/2012US20120077785 Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer, rosacea and psoriasis
03/29/2012US20120077784 Skin treatment compositions
03/29/2012US20120077781 Flavin derivatives
03/29/2012US20120077772 Solid oral dosage forms of lamivudine
03/29/2012US20120077767 Molecular predictors of fungal infection
03/29/2012US20120077764 Compositions and method for treating infection in cattle and swine
03/29/2012US20120077759 3-3-Di-Substituted-Oxindoles as Inhibitors of Translation Initiation
03/29/2012US20120077741 Treatment of Central Nervous System Disorders
03/29/2012US20120077740 Methods for making Apo-2 Ligand using divalent metal ions
03/29/2012US20120077738 Compositions and methods for predicting hcv susceptibility to antiviral agents
03/29/2012US20120077737 Hepatitis c inhibitor compounds
03/29/2012US20120077736 Inhibitor against forming biofilm comprising k-casein macropeptide
03/29/2012US20120077732 Cyclic peptides and uses thereof
03/29/2012US20120077676 Antifungal 1,2,4-Triazolyl Derivatives Having a 5-Sulfur Substituent
03/29/2012US20120076857 Forms of rifaximin and uses thereof
03/29/2012US20120076849 Plant composition for the treatment or prevention of viral blood-borne diseases such as diseases caused by the human immunodeficiency virus (hiv) or hepatitis c
03/29/2012US20120076847 Medical instrument and method of manufacturing the same
03/29/2012US20120076841 Porous Particles Loaded with Cosmetically or Pharmaceutically Active Compounds
03/29/2012US20120076835 Hiv inhibiting pyrimidines derivatives
03/29/2012US20120076829 Isolation, identification and characterisation of strains with probiotic activity, from faeces of infants fed exclusively with breast milk
03/29/2012US20120076823 Vector
03/29/2012US20120076820 Cd40l vaccines, compositions, and methods related thereto
03/29/2012US20120076819 Compositions And Methods For Treating of Microbial Infections
03/29/2012US20120076818 Immunogenic composition and use thereof
03/29/2012US20120076817 Polysaccharide-protein conjugate vaccines
03/29/2012US20120076814 Combinations of pneumococcal rrgb clades
03/29/2012US20120076813 USES OF GLUTAMYL tRNA SYNTHETASE (GtS) FRAGMENTS
03/29/2012US20120076812 Antiviral vaccines with improved cellular immunogenicity
03/29/2012US20120076811 Immunodominant compositions and methods of use therefor
03/29/2012US20120076810 Vaccinia virus polypeptides
03/29/2012US20120076807 Plasmids with immunological action
03/29/2012US20120076802 Human cytomegalovirus neutralising antibodies and use thereof
03/29/2012US20120076801 Human cytomegalovirus neutralising antibodies and use thereof
03/29/2012US20120076794 Host cell specific binding molecules capable of neutralizing viruses and uses thereof
03/29/2012US20120076773 Novel Drug Delivery Devices
03/29/2012US20120076763 Combination anti-hiv vectors, targeting vectors, and methods of use
03/29/2012US20120076758 Antibodies against west nile virus and therapeutic and prophylactic uses thereof
03/29/2012US20120076756 Novel benzimidazole derivatives
03/29/2012US20120076755 Hepatitis C Virus Inhibitors
03/29/2012US20120076742 Topical drug delivery system with dual carriers
03/29/2012US20120076738 Combination treatment for dermatological conditions
03/29/2012US20120076734 Radiopaque antibiotic dental paste and uses thereof
03/29/2012DE102010046837A1 Phenylchinazolinderivate Phenylchinazolinderivate
03/29/2012CA2830703A1 Viral inhibitor composition for in vivo therapeutic use
03/29/2012CA2812962A1 Azido nucleosides and nucleotide analogs
03/29/2012CA2812363A1 Substituted polycyclic carbamoyl pyridone derivative prodrug
03/29/2012CA2811919A1 Oral composition and method of forming and using same
03/29/2012CA2811797A1 Mosquitocidal xenorhabdus, lipopeptide and methods
03/29/2012CA2811023A1 Influenza treatment and/or characterization; human-adapted ha polypeptides; vaccines
03/29/2012CA2810928A1 Substituted nucleotide analogs
03/29/2012CA2808556A1 Therapeutic vaccination against active tuberculosis
03/29/2012CA2780785A1 Pharmaceutical composition having antimicrobial and anti-inflammatory activity for parenteral administration, process for preparing same
03/29/2012CA2780771A1 Pharmaceutical composition having antimicrobial and fast-healing activity for external administration, process for preparing sames
03/28/2012EP2434282A2 Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers
03/28/2012EP2433948A1 Use of a new class of nucleotide sugar as antibiotic or cytostatic agent
03/28/2012EP2433926A1 Pleuromutilin derivatives for use in the treatment of diseases mediated by microbes
03/28/2012EP2433648A2 Vaccine comprising an oil in water emulsion adjuvant
03/28/2012EP2433633A1 Triazolyl alpha -mercaptoacetanildes as inhibitors of HIV reverse transcriptase
03/28/2012EP2433622A1 Agent for the prophylaxis and treatment of highly pathogenic infectious diseases
03/28/2012EP2432792A1 N- [ (2 ' r) -2 ' -deoxy-2 ' -fluoro-2 ' -methyl-p-phenyl-5 ' -uridylyl]-l-alanine 1-methylethyl ester and process for its production
03/28/2012EP2432788A1 Amorphous fosamprenavir calcium
03/28/2012EP2432554A1 Heterocyclic antiviral compounds
03/28/2012EP2432504A1 Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
03/28/2012EP2432479A1 Extended acting oxygen generating composition for treating microbial infections
03/28/2012EP2432474A1 Medication for oral administration, comprising at least one estrogen and/or at least one gestagen and at least one probiotic bacterial strain
03/28/2012EP2260048B1 Porous crystalline hybrid solid for adsorbing and releasing gas of biological interest
03/28/2012EP2250163B1 Hepatitis c virus inhibitors
03/28/2012EP2178878B1 Tetracyclic compounds for the treatment of hepatitis c
03/28/2012EP1543830B1 Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides
03/28/2012EP1517700B1 Mucin fusion polypeptide vaccines, compositions and methods of use thereof
03/28/2012EP1308438B9 3-substituted urea derivatives and medicinal use thereof
03/28/2012EP1283851B1 Use of il-4r antibodies and compositions thereof
03/28/2012EP1272197B2 Combination of lecithin with ascorbic acid
03/28/2012CN1882568B Pyrrol derivatives with antibacterial activity
03/28/2012CN1827605B 4,4-disubstituted-3,4-dihydro-2(1H)- quinolones and synthesis process and use thereof
03/28/2012CN1635901B Remodeling and glycoconjugation of peptides
03/28/2012CN1434716B Anti-adhesive agent in relation to pathogenic flora of skin
1 ... 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 ... 1798